Enhancement of neovascularization in regenerating skeletal muscle by the sustained release of erucamide from a polymer matrix

Christopher Mitchell, MJ Davies, MD Grounds, JK McGeachie, GJ Crawford, Y Hong, TV Chirila

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The angiogenic agent erucamide (cis-13-docosenamide), incorporated into a polymeric biomaterial (Elvax(R) 40P, a copolymer of ethylene and vinyl acetate), was used to determine whether angiogenesis can be increased in the regenerating skeletal muscle, and whether the enhanced revascularization improves the new muscle formation. The angiogenic nature of this lipid was confirmed in a rat cornea-micropocket assay, prior to insertion of small strips of the polymer containing either 3 mu g, 30 mu g, 300 mu g erucamide or only polymer as a control into the mid-region of crush-injured tibialis anterior (TA) muscles of forty-five adult male BALB/c mice. All TA muscles were sampled ten days after injury and analyzed morphometrically. Statistical analyses of the mean blood vessel area density in lesions from twelve perfused TA muscles (three from each of the erucamide-treated or control group), revealed a dose-dependent angiogenic effect of erucamide: a dosage of 3 mu g increased mean blood vessel area density to 5.1% compared to 2.0% in controls, due to numerous large caliber, thin-walled vessels, whereas the mean vessel area density in both the 30-mu g (3.5%) and 300-mu g (1.5%) doses were similar to controls. However, at all three doses tested, erucamide did not significantly alter the degree of new muscle formation, connective tissue deposition, or removal of necrotic debris.
LanguageEnglish
Pages230-249
JournalJournal of Biomaterials Applications
Volume10
Issue number3
Publication statusPublished - Jan 1996

Fingerprint

Polymers
Skeletal Muscle
Muscles
Blood Vessels
Biocompatible Materials
Connective Tissue
Cornea
erucyl amide
Lipids
Control Groups
Wounds and Injuries
ethylenevinylacetate copolymer

Cite this

Mitchell, Christopher ; Davies, MJ ; Grounds, MD ; McGeachie, JK ; Crawford, GJ ; Hong, Y ; Chirila, TV. / Enhancement of neovascularization in regenerating skeletal muscle by the sustained release of erucamide from a polymer matrix. In: Journal of Biomaterials Applications. 1996 ; Vol. 10, No. 3. pp. 230-249.
@article{0a660adf7d5446a3937a224f998bd19e,
title = "Enhancement of neovascularization in regenerating skeletal muscle by the sustained release of erucamide from a polymer matrix",
abstract = "The angiogenic agent erucamide (cis-13-docosenamide), incorporated into a polymeric biomaterial (Elvax(R) 40P, a copolymer of ethylene and vinyl acetate), was used to determine whether angiogenesis can be increased in the regenerating skeletal muscle, and whether the enhanced revascularization improves the new muscle formation. The angiogenic nature of this lipid was confirmed in a rat cornea-micropocket assay, prior to insertion of small strips of the polymer containing either 3 mu g, 30 mu g, 300 mu g erucamide or only polymer as a control into the mid-region of crush-injured tibialis anterior (TA) muscles of forty-five adult male BALB/c mice. All TA muscles were sampled ten days after injury and analyzed morphometrically. Statistical analyses of the mean blood vessel area density in lesions from twelve perfused TA muscles (three from each of the erucamide-treated or control group), revealed a dose-dependent angiogenic effect of erucamide: a dosage of 3 mu g increased mean blood vessel area density to 5.1{\%} compared to 2.0{\%} in controls, due to numerous large caliber, thin-walled vessels, whereas the mean vessel area density in both the 30-mu g (3.5{\%}) and 300-mu g (1.5{\%}) doses were similar to controls. However, at all three doses tested, erucamide did not significantly alter the degree of new muscle formation, connective tissue deposition, or removal of necrotic debris.",
author = "Christopher Mitchell and MJ Davies and MD Grounds and JK McGeachie and GJ Crawford and Y Hong and TV Chirila",
year = "1996",
month = "1",
language = "English",
volume = "10",
pages = "230--249",
journal = "Journal of Biomaterials Applications",
issn = "0885-3282",
number = "3",

}

Mitchell, C, Davies, MJ, Grounds, MD, McGeachie, JK, Crawford, GJ, Hong, Y & Chirila, TV 1996, 'Enhancement of neovascularization in regenerating skeletal muscle by the sustained release of erucamide from a polymer matrix', Journal of Biomaterials Applications, vol. 10, no. 3, pp. 230-249.

Enhancement of neovascularization in regenerating skeletal muscle by the sustained release of erucamide from a polymer matrix. / Mitchell, Christopher; Davies, MJ; Grounds, MD; McGeachie, JK; Crawford, GJ; Hong, Y; Chirila, TV.

In: Journal of Biomaterials Applications, Vol. 10, No. 3, 01.1996, p. 230-249.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Enhancement of neovascularization in regenerating skeletal muscle by the sustained release of erucamide from a polymer matrix

AU - Mitchell, Christopher

AU - Davies, MJ

AU - Grounds, MD

AU - McGeachie, JK

AU - Crawford, GJ

AU - Hong, Y

AU - Chirila, TV

PY - 1996/1

Y1 - 1996/1

N2 - The angiogenic agent erucamide (cis-13-docosenamide), incorporated into a polymeric biomaterial (Elvax(R) 40P, a copolymer of ethylene and vinyl acetate), was used to determine whether angiogenesis can be increased in the regenerating skeletal muscle, and whether the enhanced revascularization improves the new muscle formation. The angiogenic nature of this lipid was confirmed in a rat cornea-micropocket assay, prior to insertion of small strips of the polymer containing either 3 mu g, 30 mu g, 300 mu g erucamide or only polymer as a control into the mid-region of crush-injured tibialis anterior (TA) muscles of forty-five adult male BALB/c mice. All TA muscles were sampled ten days after injury and analyzed morphometrically. Statistical analyses of the mean blood vessel area density in lesions from twelve perfused TA muscles (three from each of the erucamide-treated or control group), revealed a dose-dependent angiogenic effect of erucamide: a dosage of 3 mu g increased mean blood vessel area density to 5.1% compared to 2.0% in controls, due to numerous large caliber, thin-walled vessels, whereas the mean vessel area density in both the 30-mu g (3.5%) and 300-mu g (1.5%) doses were similar to controls. However, at all three doses tested, erucamide did not significantly alter the degree of new muscle formation, connective tissue deposition, or removal of necrotic debris.

AB - The angiogenic agent erucamide (cis-13-docosenamide), incorporated into a polymeric biomaterial (Elvax(R) 40P, a copolymer of ethylene and vinyl acetate), was used to determine whether angiogenesis can be increased in the regenerating skeletal muscle, and whether the enhanced revascularization improves the new muscle formation. The angiogenic nature of this lipid was confirmed in a rat cornea-micropocket assay, prior to insertion of small strips of the polymer containing either 3 mu g, 30 mu g, 300 mu g erucamide or only polymer as a control into the mid-region of crush-injured tibialis anterior (TA) muscles of forty-five adult male BALB/c mice. All TA muscles were sampled ten days after injury and analyzed morphometrically. Statistical analyses of the mean blood vessel area density in lesions from twelve perfused TA muscles (three from each of the erucamide-treated or control group), revealed a dose-dependent angiogenic effect of erucamide: a dosage of 3 mu g increased mean blood vessel area density to 5.1% compared to 2.0% in controls, due to numerous large caliber, thin-walled vessels, whereas the mean vessel area density in both the 30-mu g (3.5%) and 300-mu g (1.5%) doses were similar to controls. However, at all three doses tested, erucamide did not significantly alter the degree of new muscle formation, connective tissue deposition, or removal of necrotic debris.

M3 - Article

VL - 10

SP - 230

EP - 249

JO - Journal of Biomaterials Applications

T2 - Journal of Biomaterials Applications

JF - Journal of Biomaterials Applications

SN - 0885-3282

IS - 3

ER -